ROYCE & ASSOCIATES LP - CORREVIO PHARMA CORP ownership

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CORREVIO PHARMA CORP
ValueSharesWeighting
Q4 2019$41,000
-98.5%
101,100
-92.8%
0.00%
-100.0%
Q3 2019$2,827,000
+108.5%
1,413,475
+125.1%
0.03%
+116.7%
Q2 2019$1,356,000
-11.1%
628,000
+30.2%
0.01%
-7.7%
Q1 2019$1,525,000
+27.0%
482,5000.0%0.01%
+18.2%
Q4 2018$1,201,000
+17.2%
482,500
+89.3%
0.01%
+57.1%
Q3 2018$1,025,000254,9000.01%
Other shareholders
CORREVIO PHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 250,000$103,0000.68%
Tamarack Advisers, LP 2,500,000$1,019,0000.23%
Virtu Financial LLC 287,972$118,0000.01%
ARS Investment Partners, LLC 147,818$61,0000.01%
Pacifica Partners Inc. 2,665$1,0000.00%
OXFORD ASSET MANAGEMENT LLP 116,653$48,0000.00%
K.J. Harrison & Partners Inc 12,860$5,0000.00%
TORONTO DOMINION BANK 153$00.00%
SCOTIA CAPITAL INC. 19,000$8,0000.00%
MORGAN STANLEY 99,852$41,0000.00%
View complete list of CORREVIO PHARMA CORP shareholders